Pre-market hot trades in US stocks: Borealis Foods pre-market down 15.98%; TE Connectivity pre-market up 14.74%

Pre-market Hot Trades in US Stocks

Borealis Foods, down 15.98% in pre-market trading, has no significant recent news. The trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

TE Connectivity is up 14.74% in pre-market trading. There is no significant recent news; the trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no_news

Top Gainers in Pre-market US Stocks

RF Acquisition Corp II is up 449.10% in pre-market trading. Based on recent key news:

1. On August 20, RF Acquisition Corp. II released original content through the EDGAR system of the U.S. Securities and Exchange Commission, leading to increased market attention on its information and driving the stock price significantly higher.

2. On August 21, shareholders submitted a preliminary request to redeem 3.95 million shares of RFAC stock, which raised market concerns about the company's future liquidity and further boosted the stock price.

3. Recently, the stock price of RF Acquisition Corp has approached its 52-week high, and the market's positive response to its technical indicators has also contributed to the stock price increase. There is increased interest in small-cap stocks, and trading is active.

RF ACQUISITION CORP II COM USD0.0001 (S/R 15/02/2027) is up 95.45% in pre-market trading, with no significant recent news. The trading is active, with clear capital flows. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Werewolf Therapeutics is up 71.68% in pre-market trading. Based on recent key news:

1. On August 20, Werewolf Therapeutics announced the sale of its inducers and Indukine platform to EMD Serono. EMD will pay a $28 million upfront payment and an additional $5 million upon completion of the asset transfer. This news significantly boosted the stock price.

2. On August 20, Werewolf Therapeutics obtained exclusive licensing from EMD for the development of WTX-124 and WTX-330. This licensing agreement further enhances the company's future R&D potential and boosts market confidence.

3. On August 20, Werewolf Therapeutics released detailed information about the aforementioned transaction and licensing agreement through the EDGAR system of the U.S. Securities and Exchange Commission, ensuring transparency and credibility of the information, further driving the stock price up. The biotechnology industry has performed strongly recently, with significant capital inflows